Real-world Tactics to Address Health Inequities in Melanoma Care

This activity is part of a series

Faculty

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP
Clinical Professor of Medicine and Medical Oncology Department of Medical Oncology
Director, Center to Eliminate Cancer Disparities Associate Director, Diversity Affairs
Sidney Kimmel Cancer Center at Jefferson Philadelphia, PA 116th President of the National Medical Ass
Edith Peterson Mitchell, MD, MACP, FCPP, FRCP

Edith Peterson Mitchell, MD, MACP, FCPP, FRCP, is board certified in Internal Medicine and Medical Oncology and is Clinical Professor of Medicine and Medical Oncology at Sidney Kimmel Medical College at Thomas Jefferson University and Associate Director for Diversity Programs and Director of the Center to Eliminate Cancer Disparities for Sidney Kimmel Cancer Center at Jefferson.

Dr. Mitchell has spent her medical career helping individuals in medically underserved areas and has demonstrated the importance of community service and outreach, especially to underserved populations. Her research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined-modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer.

Dr. Mitchell served as the 116th President of the National Medical Association, and is a member of the American Medical Association, National Medical Association, Aerospace Medical Association, Association of Military Surgeons, Medical Society of Eastern Pennsylvania, ECOG/ACRIN Cancer Research Group, and Radiation Therapy Oncology Group. Because of her experience in the cancer research community, Dr. Mitchell served as a member of the National Cancer Institute Blue Ribbon Panel convened to advise the National Cancer Advisory Board on then Vice President Biden’s National Cancer Moonshot Initiative. In 2019, Dr. Mitchell began service as a member of the President’s Cancer Panel. In 2020, she became a Fellow of the Royal College of Physicians.

In addition to her medical achievements, Dr. Mitchell is a retired United States Air Force Brigadier General.

Susan C. Taylor, MD, FAAD
Bernett L. Johnson Endowed Professor of Dermatology
Vice Chair for Diversity, Equity and Inclusion Department of Dermatology, Perelman School of Medicine, University of Pennsylvania
Founder of the Skin of Color Society, Philadelphia, PA
Susan C. Taylor, MD, FAAD

Susan C. Taylor, MD, FAAD is a Harvard, Columbia, and University of Pennsylvania educated physician and is the Bernett L. Johnson Jr. Endowed Professor of Dermatology at the University of Pennsylvania’s Perelman School of Medicine in Philadelphia. Dr. Taylor has performed pioneering work establishing Skin of Color as a sub-specialty within Dermatology. Her work has focused on advancing clinical knowledge and addressing gaps in research and education regarding skin of color populations. She has led education, policy, and research initiatives that have invigorated a national dialogue about diversity, health disparities, and skin of color related issues.

Dr. Taylor’s clinical focus encompasses disorders that uniquely or disproportionately affect patients of color including alopecia and pigmentary disorders, cosmetic and appearance enhancing devices, and cultural competency. She serves as Principal Investigator for Phase II through Phase IV clinical research trials. Dr. Taylor has over 75 original publications and has co-edited two major dermatology textbooks.

Dr. Taylor is the Past Vice President of the American Academy of Dermatology, founder of the Skin of Color Society, and a Board Member of the Women’s Dermatology Society.

Statement of Need

Where the predominance of melanoma is seen in White people, roughly 20 times that of Black people, the weight of later stage presentation, delayed treatment, and poorer outcomes falls on those of racial and ethnic underserved populations. A culmination of biases, disparities, and inequities continues a cycle of inadequate oncology treatment for melanoma, thus resulting in delayed diagnosis and suboptimal clinical management, prognosis, and survival rate.

In this CME Outfitters BriefCase, a faculty expert will guide learners through a patient case scenario reflective of the impact of biases, disparities, and health inequities that reduce the quality of oncology care for racial and ethnic underserved patients with melanoma. This program will provide actionable strategies, empowering attendees to recognize factors and implement changes in practice to improve melanoma treatment.

Learning Objectives

At the end of this CME/CE activity, participants should be able to recognize the impact of health inequities on patients with melanoma when crafting individual treatment strategies for optimal outcomes.

Financial Support

Supported by an educational grant from the Johnson & Johnson Institute and the Johnson & Johnson Family of Companies.

Target Audience

Physicians, physician associates (PAs), nurse practitioners (NPs), nurses/nurse navigators, pharmacists, and dietitians specializing in oncology, pathology, radiology, dermatology, and primary care

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.5

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) Credit for learning and change.

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.5

This activity is designated for 0.5 contact hours.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.5 contact hours (0.05 CEUs) of continuing pharmacy credit.
Activity UAN: JA0007185-0000-22-132-H01-P

Physician Assistants (AAPA): 0.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

Dietetics (CDR)

Completion of this RD/DTR profession-specific or IPCE activity awards CPEUs (One IPCE credit = One CPEU). If the activity is dietetics-related but not targeted to RDs or DTRs, CPEUs may be claimed which are commensurate with participation in contact hours (One 60 minute hour = 1 CPEU). RDs and DTRs are to select activity type 102 in their Activity Log. Performance indicator selection is at the learner’s discretion.

Case Management (CCMC) 0.5

This program has been pre-approved by The Commission for Case Manager Certification to provide continuing education credit to CCM® board-certified case managers. The course is approved for 0.5 CE contact hours.

ABIM MOC 0.5

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.


Dr. Mitchell reports the following financial relationships: Advisory Board: Corvus Pharmaceuticals, Inc. Consultant: Amgen Inc.; Astellas Pharma Inc.; Bristol Myers Squibb; Genentech, Inc.; and SEMA4 OpCo, Inc.


Dr. Taylor reports the following financial relationships: Advisory Board: AbbVie Inc.; Beiersdorf; Biorez; Galderma Laboratories, L.P.; GloGetter; Hugel America, Inc.; Janssen Pharmaceuticals, Inc.; L’Oreal USA; Medscape; Scientis SA; and UCB, Inc. Consultant: Arcutis Biotherapeutics; Armis Biopharma; Beiersdorf; Cara Therapeutics; EPI Health; Evolus, Inc.; Johnson & Johnson; Piction Health; and Vichy Laboratories. Grants: Pfizer Inc. Research Support: Concert Pharmaceuticals; Croma-Pharma GmbH; and Eli Lilly and Company. Speakers Bureau: BureauBeiersdorf; Evolus, Inc.; L’Oreal USA; Medscape; and MJH Life Sciences. Stock Shareholder (stock options): Armis Biopharma; GloGetter; and Piction Health. Other Financial or Material Support: McGraw Hill (book royalties) and Mercer Strategies (Board of Directors)


The following peer reviewer and CME Outfitters staff have no financial relationships:

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • Meghann Taft-Lockard (planning committee)
  • David Modrak, PhD (planning committee)
  • Sandra Caballero, PharmD (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credits

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.

BC-071-091322-57

 

Real-world Tactics to Address Health Inequities in Melanoma Care
Event Date: 09/13/2022 at 4:00 am EST